This company has a mixed profile, with a healthy balance sheet and supportive analyst views, although its current valuation deserves attention.
Quant Score on a 1–100 scale, computed Oct 24, 6:09 AM EDT from the data shown on this page. It describes the company’s current profile — it is not a price prediction or a recommendation. How it’s calculated
Tap any area to see the numbers it is based on.
The case for, the case against, and what to watch.
Is the business growing, profitable and able to carry its debt?
Is the stock reasonably priced?
The stock looks expensive relative to its earnings and cash flow, so expectations are high.
See how it stacks up on quality, growth, valuation, risk and momentum.
Is this a profitable, well-run business?
Weak. Strongest signal: free cash flow / operating cash flow at 73%. Weakest: return on equity (ttm) at -300.1%.
| Input | Value | Points /10 |
|---|---|---|
| Return on equity (TTM) | -300.1% | 0.0 |
| Return on invested capital (TTM) | 7.9% | 1.8 |
| Operating margin (TTM) | 17.4% | 4.1 |
| Net margin (TTM) | -230.1% | 0.0 |
| Free cash flow / operating cash flow | 73% | 7.2 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is this a financially healthy business?
Strong. Strongest signal: altman z-score at 13.43.
| Input | Value | Points /10 |
|---|---|---|
| Piotroski F-Score | 5/9 | 5.0 |
| Altman Z-Score | 13.43 | 10.0 |
| Debt / Equity | 0.36 | 8.6 |
| Current ratio | 1.7x | 5.2 |
| Interest coverage | 24.1x | 10.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock expensive?
Expensive. Strongest signal: peg at 0.00. Weakest: p/e (ttm) at -9.0x.
| Input | Value | Points /10 |
|---|---|---|
| P/E (TTM) | -9.0x | 0.0 |
| PEG | 0.00 | 10.0 |
| Price / FCF | 137.3x | 0.0 |
| EV / EBITDA | -10.9x | n/a |
| DCF upside | -120.1% | 0.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the company growing?
Growing. Strongest signal: revenue growth (fy) at 83.2%. Weakest: net income growth (fy) at -26876.4%.
| Input | Value | Points /10 |
|---|---|---|
| Revenue growth (FY) | 83.2% | 10.0 |
| Net income growth (FY) | -26876.4% | 0.0 |
| Revenue CAGR (3Y) | 19.5% | 6.5 |
| Forward revenue growth | 108.8% | 10.0 |
| Gross margin | 41.7% | 4.3 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock price showing strength?
Sideways. Strongest signal: trend alignment (50/200 sma) at 2/3. Weakest: macd histogram at -30.63.
| Input | Value | Points /10 |
|---|---|---|
| Trend alignment (50/200 SMA) | 2/3 | 6.7 |
| RSI (14) | 38.5 | 6.0 |
| MACD histogram | -30.63 | 2.0 |
| Signal consensus | Sell | 4.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What do professional analysts think?
Positive. Strongest signal: target upside at 33.3%.
| Input | Value | Points /10 |
|---|---|---|
| Analyst buy share | 72% | 7.0 |
| Target upside | 33.3% | 8.7 |
| 90-day rating revisions | 0↑ / 0↓ | 5.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What could go wrong?
High risk. Strongest signal: net debt / ebitda at 0.1x. Weakest: price volatility (1y, annualised) at 98%.
| Input | Value | Points /10 |
|---|---|---|
| Beta (vs. market) | 1.54 | 3.3 |
| Price volatility (1Y, annualised) | 98% | 0.0 |
| Largest 1Y drawdown | -43% | 1.7 |
| Net debt / EBITDA | 0.1x | 9.9 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
A formula-based estimate from projected cash flows. Small changes in assumptions move it a lot — treat it as one input, not a price the stock will reach.
Range $820.00–$1,270.00. Analysts' 12-month opinions; they are frequently wrong and are not our forecast.
Source: Financial Modeling Prep · P/E trailing twelve months; history from annual filings · USD · data as of Oct 19, 2026
Revenue is what customers paid the company. Over 4 years it has grown about 15% a year on average.
Net income is the profit left after all costs and taxes. Over 4 years it has shrunk about NaN% a year on average.
Cash the business generates after investing in itself — what can fund dividends, buybacks or growth. Over 4 years it has shrunk about 5% a year on average.
Share of sales left after the direct cost of products.
Share of sales left after running the business.
Share of sales kept as profit.
Debt is moderate compared with shareholders' equity.
Returns on invested money are around average.
Profits cover interest payments many times over.
Source: Financial Modeling Prep · annual filings FY2022–FY2026; margins and ratios trailing twelve months · USD · data as of Oct 19, 2026
